The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognostic significance of reduction rate of Ki-67 after neoadjuvant chemotherapy in breast cancer patients with non-pCR.
Nobuaki Matsubara
No relevant relationships to disclose
Hirofumi Mukai
No relevant relationships to disclose
Yoichi Naito
No relevant relationships to disclose
Ako Hosono
No relevant relationships to disclose
Kuniaki Itoh
No relevant relationships to disclose
Satoshi Fujii
No relevant relationships to disclose
Kimiyasu Yoneyama
No relevant relationships to disclose
Noriaki Wada
No relevant relationships to disclose